| Followers | 12 |
| Posts | 1963 |
| Boards Moderated | 0 |
| Alias Born | 04/16/2024 |
Wednesday, July 17, 2024 9:25:01 AM
Recent LGVN News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:45:34 PM
- Longeveron® Appoints Stephen H. Willard as Chief Executive Officer • GlobeNewswire Inc. • 02/13/2026 09:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 07:15:19 PM
- Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program • GlobeNewswire Inc. • 02/05/2026 02:15:00 PM
- Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs) • GlobeNewswire Inc. • 01/29/2026 02:15:00 PM
- Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) • GlobeNewswire Inc. • 01/26/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:00:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:00:14 PM
- Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026 • GlobeNewswire Inc. • 12/29/2025 02:15:00 PM
- Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy • GlobeNewswire Inc. • 12/17/2025 02:15:00 PM
- Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum • GlobeNewswire Inc. • 12/03/2025 02:15:00 PM
- Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging • GlobeNewswire Inc. • 12/02/2025 02:15:00 PM
- Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025) • GlobeNewswire Inc. • 12/01/2025 05:00:00 PM
- Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025) • GlobeNewswire Inc. • 11/19/2025 02:15:00 PM
- Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy • GlobeNewswire Inc. • 11/12/2025 02:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 11:20:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 09:15:18 PM
- Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/04/2025 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2025 09:00:55 PM
- Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 • GlobeNewswire Inc. • 10/28/2025 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2025 10:00:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2025 10:00:09 PM
FEATURED LaFleur Minerals Progressing Towards Gold Pour at Beacon Gold Mill in Val-d'Or, Québec • Feb 18, 2026 9:01 AM
Closing the Intent-to-Execution Gap May Define Next Wave of AI Investment • WLDS • Feb 17, 2026 9:00 AM
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • ARWR • Feb 17, 2026 9:00 AM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
